Antiangiogenic therapy using nanotechnological-based delivery system (Q37832023)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on January 22, 2011

Language	Label	Description	Also known as
English	Antiangiogenic therapy using nanotechnological-based delivery system	scientific article published on January 22, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Antiangiogenic therapy using nanotechnological-based delivery system (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

1

object named as

Jagat R Kanwar

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Ganesh Mahidhara

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Rupinder K. Kanwar

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21262383

22 November 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21262383

22 November 2024

publication date

22 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1359644611000080?httpAccept=text/xml

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

https://api.elsevier.com/content/article/PII:S1359644611000080?httpAccept=text/plain

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Drug Discovery Today

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

188-202

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.ACTBIO.2010.08.010

Molecular aspects of tumor cell invasion and metastasis

1

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The p53 pathway: positive and negative feedback loops

2

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Molecular mechanisms of tumor angiogenesis and tumor progression

3

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Angiogenesis in cancer, vascular, rheumatoid and other disease

4

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle

5

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

6

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Mutation and cancer: statistical study of retinoblastoma

7

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

John Kerr and apoptosis.

8

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Apoptosis in the pathogenesis and treatment of disease

9

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains

10

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

CD95's deadly mission in the immune system

11

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The Fas signaling pathway: more than a paradigm

12

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

13

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Two CD95 (APO-1/Fas) signaling pathways

14

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Survivin study: what is the next wave?

15

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Survivin study: an update of "what is the next wave"?

16

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer

17

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy

18

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Lentivirus-mediated gene therapy by suppressing survivin in BALB/c nude mice bearing oral squamous cell carcinoma

19

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells

20

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Targeting survivin in cancer: patent review

21

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells

22

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

How the field of controlled-release technology began, and its central role in the development of angiogenesis research

23

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cancer without disease.

24

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

New perspectives in clinical oncology from angiogenesis research

25

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

26

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells

27

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch

28

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression

29

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice

30

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis

31

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

MicroRNA maturation: stepwise processing and subcellular localization

32

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The nuclear RNase III Drosha initiates microRNA processing

33

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

MicroRNA biogenesis and cancer

34

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

35

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

microRNAs: tiny regulators with great potential

36

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The functions of animal microRNAs

37

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

38

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

39

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

MicroRNA in human cancer and chronic inflammatory diseases

40

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

41

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

RAS is regulated by the let-7 microRNA family

42

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

43

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

let-7 microRNA functions as a potential growth suppressor in human colon cancer cells

44

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Reduced accumulation of specific microRNAs in colorectal neoplasia

45

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A microRNA expression signature of human solid tumors defines cancer gene targets

46

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis

47

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma

48

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

49

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

50

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

51

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

52

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Transcriptional Regulation by Hypoxia-Inducible Factor 1 Molecular Mechanisms of Oxygen Homeostasis

53

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A microRNA signature of hypoxia

54

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3

55

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression

56

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis

57

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

58

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

miR-126 regulates angiogenic signaling and vascular integrity

59

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The von Hippel-Lindau tumor suppressor gene

60

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Regression of solid tumors by engineered overexpression of von Hippel–Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1α

61

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells

62

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

63

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases

64

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cytoplasmic RNA modulators of an inside-out signal-transduction cascade

66

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

67

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.

68

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer

69

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Therapeutic effects of matrine on primary and metastatic breast cancer

70

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Requirements for ICAM-1 immunogene therapy of lymphoma

71

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy

72

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

73

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

74

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

75

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

76

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Viral RNA silencing suppressors (RSS): Novel strategy of viruses to ablate the host RNA interference (RNAi) defense system

77

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Interfering with disease: a progress report on siRNA-based therapeutics

78

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

siRNA-based approaches in cancer therapy

79

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas

80

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors

81

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Mouse B7-H3 induces antitumor immunity.

82

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity

84

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Vector-Based in Vivo RNA Interference: Dose- and Time-Dependent Suppression of Transgene Expression

86

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

87

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Long-term RNA interference from optimized siRNA expression constructs in adult mice

88

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth

89

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cell cycle arrest drastically extends the duration of gene silencing after transient expression of short hairpin RNA.

90

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats

91

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides

92

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A pseudosymmetric cell adhesion regulatory domain in the beta7 tail of the integrin alpha4beta7 that interacts with focal adhesion kinase and src.

93

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Gene therapy progress and prospects: synthetic polymer-based systems.

94

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cationic lipids and polymers mediated vectors for delivery of siRNA.

95

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Gene delivery by cationic lipid vectors: overcoming cellular barriers

96

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Aptamer-targeted cell-specific RNA interference

97

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Identification of liver cancer-specific aptamers using whole live cells

98

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

99

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Nanotechnology and aptamers: applications in drug delivery

100

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Therapeutic applications of DNA and RNA aptamers.

101

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

102

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Aptamer mediated siRNA delivery

103

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2.

104

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

105

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro

106

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay

107

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cellular uptake of the tat protein from human immunodeficiency virus

109

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

110

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration

111

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus

112

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Intercellular trafficking and protein delivery by a herpesvirus structural protein

113

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cell penetration by transportan.

115

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

117

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

In vivo protein transduction: delivery of a biologically active protein into the mouse

118

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta

119

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Delivery of bioactive molecules into the cell: the Trojan horse approach

121

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cell-penetrating peptides: mechanism and kinetics of cargo delivery

122

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

123

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation

124

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation.

125

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells.

126

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.

127

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A peptide carrier for the delivery of biologically active proteins into mammalian cells.

128

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.

129

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis.

130

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

131

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells

132

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect

133

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

134

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Transvascular delivery of small interfering RNA to the central nervous system.

135

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

An intracellular delivery method for siRNA by an arginine-rich peptide

136

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea

137

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells

138

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells

139

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.

140

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Intracellular delivery of antibodies using TAT fusion protein A

141

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate

142

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Crystal structure at 1.92 A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin

143

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Interaction of N-terminal domain of U1A protein with an RNA stem/loop

144

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery

145

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Multicolor Coding of Cells with Cationic Peptide Coated Quantum Dots

146

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue

150

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability

151

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.

152

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Immobilization of enzymes on slowly soluble carriers

153

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Water-based nanoparticulate polymeric system for protein delivery: permeability control and vaccine application

154

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

155

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Lipid vesicles and other colloids as drug carriers on the skin

156

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Polymer conjugates as anticancer nanomedicines

157

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Cellular localisation of a water-soluble fullerene derivative

158

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

The emerging field of nanotube biotechnology

159

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Nanocarriers: promising vehicle for bioactive drugs

160

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme

161

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

163

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Nanocarriers as an emerging platform for cancer therapy

164

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

165

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles

166

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Incorporation of a model protein into chitosan-bile salt microparticles

168

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Protein delivery from biodegradable microspheres.

169

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin

170

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

NanoBiotech 2008: Exploring global advances in nanomedicine

171

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Survivin: a target from brain cancer to neurodegenerative disease.

172

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy

174

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Regulation of the germinal center response by microRNA-155

175

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock

176

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

177

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

178

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells

179

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.

180

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Photo inducible RNA interference using cell permeable protein carrier

181

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system

182

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing.

183

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine).

184

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

185

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting

186

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Highly sensitive optical chip immunoassays in human serum

187

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs

188

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer

189

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide

190

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.

191

1 reference

10.1016/J.DRUDIS.2011.01.007

https://api.crossref.org/works/10.1016/J.DRUDIS.2011.01.007

22 November 2024

Identifiers

10.1016/J.DRUDIS.2011.01.007

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

release_rxqtn4rqbzafzbzzdfye5mwsga

1 reference

https://api.fatcat.wiki/v0/release/rxqtn4rqbzafzbzzdfye5mwsga

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37832023&oldid=2278392456"